Autoimmune & Arthritis
Antisense Drug Achieves Functional Cure in 19% of Chronic Hepatitis B Patients
Phase 3 trials show bepirovirsen delivers functional cure in nearly 1 in 5 chronic HBV patients — a landmark result in a disease with few curative options.
Video
Jun 29, 2026 0